Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis

Pancreas

Volumn 39, Issue 4, 2010, Pages 516-519

  Lu, Xin Sheng ^a   Qiu, Fu ^a   Li, Yi Xiong ^a   Li, Jie Qin ^b   Fan, Qin Qiao ^c   Zhou, Ri Guang ^d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b No 163 Central Hospital of PLA   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d Central Hospital of Longgang District   (China)

Author keywords

LowYmolecular weight heparin; Pancreatic encephalopathy; Severe acute pancreatitis

Indexed keywords

AMYLASE; ANTIBIOTIC AGENT; CEPHALOSPORIN; FIBRINOGEN; HEPARIN; LOWER Y MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; OCTREOTIDE; OMEPRAZOLE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENZYME BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS NECROSIS; PANCREATIC ENCEPHALOPATHY; PANCREATITIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMYLASES; ANTICOAGULANTS; BRAIN DISEASES; CHILD; FEMALE; FIBRINOGEN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951741060     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181c3c954     Document Type: Article

References (15)

1. Schneider L, Peitschmann M, Hartwig W, et al. Inosin reduce microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg. 2006;191:510-514.
2. Karne S, Gorelick FS. Etiopathogenesis of acute pancreatitis. Surg Clin N Am. 1999;79:699-710.
3. Wang ZF, Pan CE, Lu Y, et al. The role of inflammatory mediators in severe acute pancreatitis and regulation of glucocorticoids. Hepatobiliary Pancreat Dis Int. 2003;2:458-462.
4. Menza MA, Murraay GB. Pancreatic encephalopathy. Biol Psychiatry. 1989;25:781-785.
5. Qiu F, Lu X-S, Huang Y-K. Effect of low molecular weight heparin on pancreatic microcirculation in severe acute pancreatitis in a rodent model. Chin Med J. 2007;120:2260-2263.
6. Pancreas Branch of Chinese Surgical Association. Criteria of the clinical diagnosis and classification of acute pancreatitis [in Chinese]. Chin J Surg. 1997;35:773-775.
7. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology. 2002;223:603-613.
8. Marshall JC, Cook DJ, Christon NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638-1652.
9. Norman JG, Fink GW, Yang G, et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci. 1997;42: 1783-1788.
10. Bhitia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs. 2001;2:496-501.
11. Cuthbertson CM, Christophi C. Disturbance of the microvasculation in acute pancreatitis. Br J Surg. 2006;93:518-530.
12. Farkas G, Marton J, Nagy Z, et al. Experimental acute pancreatitis in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett. 1998;243: 147-150.
13. Zhang XP, Tian H. Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2007;6:134-140.
14. Leizorovicz A, Simonnrau G, Decousus H, et al. Comparison of efficacy and safety of lower molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. Br Med J. 1994;309:229-304.
15. Sandercock PA, Counsell C, Tseng MC. LowYmolecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke. Cochrane Database Syst Rev. 2008;16(3):CD000119.